Active Ingredient Obinutuzumab
Active Ingredient Details
What is Obinutuzumab?
anti-CD20 mAb for treating B-cell lymphoid cancers
What is the usage for Obinutuzumab?
Obinutuzumab is used to treat certain types of blood cancer (such as chronic lymphocytic leukemia, follicular lymphoma). Obinutuzumab belongs to a class of drugs known as monoclonal antibodies. It works by stopping the growth of cancer cells.
How many products in the NDC database contain Obinutuzumab?
The NDC database has 1 products with the active ingredient Obinutuzumab. The following table lists all the products that have this active ingredient.
NDC Products with Obinutuzumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 50242-070 | Proprietary Name: Gazyva | Obinutuzumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE |
